 CAMBRIDGE, Mass., March 05, 2021 GLOBE NEWSWIRE -- Vor Biopharma Nasdaq: VOR, a cell therapy company pioneering engineered hematopoietic stem cell eHSC therapies combined with targeted therapies for the treatment of cancer, today announced that the Company will be participating in the Barclays Global Healthcare Conference, which will take place virtually on March 9-11, 2021. 